Published on
December 11, 2018
- 15:00 GMT
HIGHTIDE THERAPEUTICS TO PRESENT AT BIOTECH SHOWCASE 2019 IN SAN FRANCISCO
Founder CEO & CSO Dr. Liping Liu to provide introduction and overview of HTD1801, the company's lead drug candidate for chronic liver diseases (NASH, PSC) ROCKVILLE, MD, USA, December 11, 2018 /EINPresswire.com/ -- Dr. Liping Liu, Founder, CEO …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
